|
Volumn 8, Issue 9, 2013, Pages
|
Levosimendan: a cardiovascular drug to prevent liver ischemia-reperfusion injury?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ASPARTATE AMINOTRANSFERASE;
CARDIOTONIC AGENT;
HEAT SHOCK PROTEIN 72;
HYDRAZONE DERIVATIVE;
NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;
PYRIDAZINE DERIVATIVE;
SIMENDAN;
ANIMAL;
ARTICLE;
BLOOD;
DNA DAMAGE;
DRUG EFFECT;
IMMUNOHISTOCHEMISTRY;
LIVER;
MALE;
METABOLISM;
MICROCIRCULATION;
MITOCHONDRION;
OXIDATION REDUCTION REACTION;
PATHOPHYSIOLOGY;
RAT;
REPERFUSION INJURY;
TIME;
TREATMENT OUTCOME;
VASCULARIZATION;
WESTERN BLOTTING;
WISTAR RAT;
ALANINE TRANSAMINASE;
ANIMALS;
ASPARTATE AMINOTRANSFERASES;
BLOTTING, WESTERN;
CARDIOTONIC AGENTS;
DNA DAMAGE;
HSP72 HEAT-SHOCK PROTEINS;
HYDRAZONES;
IMMUNOHISTOCHEMISTRY;
LIVER;
MALE;
MICROCIRCULATION;
MITOCHONDRIA;
OXIDATION-REDUCTION;
POLY(ADP-RIBOSE) POLYMERASES;
PYRIDAZINES;
RATS;
RATS, WISTAR;
REPERFUSION INJURY;
TIME FACTORS;
TREATMENT OUTCOME;
MLCS;
MLOWN;
|
EID: 84891793214
PISSN: None
EISSN: 19326203
Source Type: Journal
DOI: 10.1371/journal.pone.0073758 Document Type: Article |
Times cited : (17)
|
References (0)
|